HOME >> BIOLOGY >> NEWS
Revised guidelines published for testing for hereditary type of colorectal cancer

An international group of experts has updated a set of criteria for testing patients with colorectal cancer to determine whether the cancer is a specific type that is inherited and therefore may mean that a patient's family members are at an increased risk of the disease. The revised Bethesda Guidelines are published in the February 18 issue of the Journal of the National Cancer Institute.

Hereditary nonpolyposis colorectal cancer (HNPCC) usually occurs in patients younger than age 45 and can result in the development of cancers in a variety of tissues, such as the colon, rectum, endometrium, stomach, ovaries, brain, and skin. A major genetic characteristic of HNPCC tumors is microsatellite instability (MSI). Microsatellites are short repeated sequences of DNA, and MSI results when mutations in genes that are responsible for repairing damaged DNA cause microsatellites to become longer or shorter. Cancers that exhibit MSI account for about 15% of all colorectal cancers.

Because HNPCC results from inherited mutations, it is possible that family members of patients with HNPCC also have the genetic characteristics that put them at an increased risk for cancers associated with a particular mutation. In 1997, a panel of experts created the Bethesda Guidelines, which outlined criteria for testing tumors from patients with colorectal cancer for MSI so scientists can better understand the development process of HNPCC and identify patients with the syndrome. Such testing would also allow affected family members to take measures to reduce their risk of developing HNPCC-associated cancers.

In a commentary, Asad Umar, D.V.M., Ph.D., of the National Cancer Institute, and colleagues summarize a meeting in 2002 at which experts looked at the most recent evidence about HNPCC gene mutations and revised the Bethesda Guidelines for testing colorectal tumors for MSI. The revised criteria suggest that tumors from patients with colorectal cancer should be tested f
'"/>

Contact: Katherine Arnold
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
17-Feb-2004


Page: 1 2

Related biology news :

1. Revised model of protein-drug interactions could make job of drug designers a little easier
2. New guidelines show significant benefits of FUZEON for wide range of pre-treated HIV/AIDS patients
3. International critical care doctors release first-ever guidelines for sepsis
4. New ACOG guidelines on progesterone to prevent preterm birth praised by March of Dimes
5. Ethical guidelines needed before nutrigenomic groceries come to market
6. New guidelines can help health officials better predict and control dengue epidemics
7. Researchers develop guidelines to establish identity of genes responsible for complex diseases
8. Aborigine study suggests body mass index guidelines should be lower to block diabetes
9. New nutrition guidelines for diabetics promote emphasis on high-monounsaturated fat diet
10. Conservation International and Starbucks announce new coffee sourcing guidelines
11. Report on dietary supplements containing ephedra makes urgent call for research to develop dose guidelines, safety warnings

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2019)... ... August 20, 2019 , ... ... second time since BioInformatics first fielded the survey in 2016. The results ... Experience , from BioInformatics, part of Science and Medicine Group. More than 800 ...
(Date:8/15/2019)... ... August 15, 2019 , ... Serialization deadlines in ... become increasingly complex, and aggregation becomes fully applied in the United States in ... long-term solution. , Until now, most regulations?including the Drug Supply Chain Security Act ...
(Date:8/14/2019)... LAKE CITY, and MARTINSRIED, Germany (PRWEB) , ... ... ... in high-throughput antibody screening and characterization, announced today that they have opened a ... Carterra’s platform has fueled the need for the new office. , The Munich ...
Breaking Biology News(10 mins):
(Date:8/4/2019)... ... ... Cirtec Medical Corporation, a strategic outsourcing partner for complex medical devices, including active ... 30,000 sq. ft. manufacturing facility in the Coyol free zone, located in Alajuela, ... expected to be fully operational by the end of the year, will be the ...
(Date:7/19/2019)... ... July 18, 2019 , ... World renowned two-time Everest summiter ... with California-based charity Coalition Duchenne for its 9th Annual Expedition Mt. Kinabalu in ... funding for Duchenne muscular dystrophy and was founded by Sabahan Catherine Jayasuriya. ...
(Date:7/9/2019)... ... , ... Today, at the BIO World Congress on Industrial Biotechnology ... announced the winners of the Consider Corn Challenge II. Three winners were chosen, each ... produce biobased materials. , “Corn is a sustainable, abundant and affordable industrial ...
(Date:6/18/2019)... , ... June 18, 2019 , ... Personalized Stem ... New Drug (IND) application to the FDA for use of a person’s own adipose-derived ... a treatment of osteoarthritis in the knee. This IND is the first of ...
Breaking Biology Technology:
Cached News: